Free Content:

Original Research, Z. h0 j) [8 }3 r* t

+ c, u6 @* s  i, ~/ \; I1 _7 ~: |9 eComparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes
0 H& x( f0 c* l; fKaspar Berneis, Manfredi Rizzo, Christoph Stettler, Bernard Chappuis, Monica Braun, Peter Diem, Emanuel R Christ
$ H) u# G& T6 }$ z4 eExpert Opinion on Pharmacotherapy, February 2008, Vol. 9, No. 3, Pages 343-349.# P6 J0 Y  U) X# o# i& }  M) j' v! v

6 L8 o7 ]* y% v( Q2 J& QReviews
& U2 ?$ |" v1 e0 r8 H, j
' s" U% e+ k" u! ]Pharmacotherapy of insomnia! `, t- _" e9 s8 ^% _
Abid Bhat, Fariha Shafi, Ali A El Solh
. V# j* V2 b! v% sExpert Opinion on Pharmacotherapy, February 2008, Vol. 9, No. 3, Pages 351-362.
" H, F9 T; W8 F: N8 R4 k7 L
$ [( P- w) J4 S& k4 E2 r5 D7 _+ zPharmacogenomics in acute coronary syndrome( A! Q8 U1 C+ P; L
Cornelia Remmler, Ingolf Cascorbi3 Z$ ?* ^3 \4 g$ J" e# D- K" Q2 C! L
Expert Opinion on Pharmacotherapy, February 2008, Vol. 9, No. 3, Pages 363-376." r0 e; b$ {- ?
9 H9 V7 [$ {1 I, \- Q' ^+ B8 s
Antiplatelet therapy with clopidogrel and aspirin in vascular diseases: clinical evidence for and against the combination
+ |! k1 N4 W# a0 kRamez R Fares, Lawrence S Lansing, Christine A Gallati, Shaker A Mousa
$ Z: Y; `7 ~; W2 x$ P% WExpert Opinion on Pharmacotherapy, February 2008, Vol. 9, No. 3, Pages 377-386.* ]) i7 t1 D5 Z
: M6 c& T; s& ~: p  E# S) z
Oral healthcare for HIV-infected patients: an international perspective
8 B! b. M. a, Z* C: @; A& V: AAM Hegarty, SI Chaudhry, TA Hodgson
' r: Z* T# f# jExpert Opinion on Pharmacotherapy, February 2008, Vol. 9, No. 3, Pages 387-404.
# |3 ]. v9 M, e! W* p( N" B0 c
  P7 x9 D& A+ rClinical trials with thiazolidinediones in subjects with Type 2 diabetes – is pioglitazone any different from rosiglitazone?) A1 K: \  G' X( o0 j
Sheila A Doggrell
/ Y4 P9 W) d% R. [9 J/ M( dExpert Opinion on Pharmacotherapy, February 2008, Vol. 9, No. 3, Pages 405-420.
! M: z4 v% Z& ~
- _* U8 [9 U* F3 \3 ~Recommendations for thyroxin therapy during pregnancy
+ s3 e4 i: |. ^7 [Venetsana Kyriazopoulou, Marina Michalaki, Neoklis Georgopoulos, Apostolos G Vagenakis$ P- i- N* b9 D( C) {
Expert Opinion on Pharmacotherapy, February 2008, Vol. 9, No. 3, Pages 421-427.. j9 I( l( r/ s! X2 L  j3 j8 S

  J1 v* `; n/ v& \3 F- W) N5 A' |The pharmacologic management of premenstrual dysphoric disorder' u* Z1 D  C- N
Andrea J Rapkin, Sharon A Winer
" I" y# t! w2 F+ l# D( g" PExpert Opinion on Pharmacotherapy, February 2008, Vol. 9, No. 3, Pages 429-445.
0 l* y7 K8 o& T" v9 }1 W . r, P1 `! O; ]7 z# z/ ^  h
Severe ulcerative colitis: present medical treatment strategies5 u$ ]" w3 y" ?
Agnès Baudet, Gabriel Rahmi, Anne-Laure Bretagne, Romain Gloro, Anne-Marie Justum, Jean-Marie Reimund% u/ k, L1 [+ Y" z5 E% o+ z: B
Expert Opinion on Pharmacotherapy, February 2008, Vol. 9, No. 3, Pages 447-457.  c4 Z: C" j8 [. e
6 j# |+ ~0 J) q
Drug Evaluations
  h( R; ^- G1 A9 J0 L5 d1 W- ?
$ f! S" ~9 e6 b& P# G7 @Clozapine use in children and adolescents
- K7 V7 {0 _3 p4 V' LNitin Gogtay, Judith Rapoport
& ~$ a- j# d% IExpert Opinion on Pharmacotherapy, February 2008, Vol. 9, No. 3, Pages 459-465.0 f1 O2 h2 M4 z# p1 d4 Q1 L" n: ~

5 \$ Y* P. |8 Y- zOlanzapine for the treatment of bipolar disorder in children and adolescents
1 o+ p7 E# f' oJeffrey R Strawn, Melissa P DelBello
1 d$ l' w+ g, P% n4 tExpert Opinion on Pharmacotherapy, February 2008, Vol. 9, No. 3, Pages 467-474.) K$ b  ?# w% f4 Q% G: Y* y  W, n

" G& S# z0 ~! O) x' V3 RAerosolized lucinactant: a potential alternative to intratracheal surfactant replacement therapy
% Y2 h$ a" q% o& Q3 }2 q6 c1 cSteven M Donn, Sunil K Sinha
" D* H" A; _3 Y+ M" iExpert Opinion on Pharmacotherapy, February 2008, Vol. 9, No. 3, Pages 475-478.
; I/ i; }9 I( x7 Q- j
2 E# y( B/ d5 D# Y3 aInhaled beclometasone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives
* K, k3 G, a+ m7 n0 O' P3 q9 Q( D, ZLeonardo Michele Fabbri, Gabriele Nicolini, Dario Olivieri, Alberto Papi
# X  ~  ?" O7 n- m/ {: `Expert Opinion on Pharmacotherapy, February 2008, Vol. 9, No. 3, Pages 479-490.
* h/ Z" W) ^, e+ { ; a/ S+ k( j7 X- L% t
Alendronate for the treatment of osteoporosis in men9 Y5 R) r" j  i1 U
WP Olszynski, KS Davison7 l0 g6 s: u/ j& N5 J3 ^3 z
Expert Opinion on Pharmacotherapy, February 2008, Vol. 9, No. 3, Pages 491-498.- \% ]) ]+ b" P* f
+ c' d) I& C9 g+ k
Pegaptanib sodium for the treatment of age-related macular degeneration8 ?# m7 J6 r  r& K- h3 B9 x. Q* J" d; t
Rajendra S Apte- c" C& Q9 q" V
Expert Opinion on Pharmacotherapy, February 2008, Vol. 9, No. 3, Pages 499-508.

! V7 V4 A: ?& V# c5 t

the hidden contents only visible for repliers

thank you very much

thankssssssssssssssssss

Thanks very good journal

let me see

Dear Blega - thanks for sharing.. Can you pls post the remaning/Current editions of the elite journal- thanks once again..

thank you very much

Thank you so much